JP2008515793A5 - - Google Patents

Download PDF

Info

Publication number
JP2008515793A5
JP2008515793A5 JP2007534071A JP2007534071A JP2008515793A5 JP 2008515793 A5 JP2008515793 A5 JP 2008515793A5 JP 2007534071 A JP2007534071 A JP 2007534071A JP 2007534071 A JP2007534071 A JP 2007534071A JP 2008515793 A5 JP2008515793 A5 JP 2008515793A5
Authority
JP
Japan
Prior art keywords
labeled
compound
protected
fdg
alkanoate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007534071A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008515793A (ja
JP5000521B2 (ja
Filing date
Publication date
Priority claimed from GBGB0422004.2A external-priority patent/GB0422004D0/en
Application filed filed Critical
Publication of JP2008515793A publication Critical patent/JP2008515793A/ja
Publication of JP2008515793A5 publication Critical patent/JP2008515793A5/ja
Application granted granted Critical
Publication of JP5000521B2 publication Critical patent/JP5000521B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2007534071A 2004-10-05 2005-09-23 脱保護の方法 Expired - Fee Related JP5000521B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0422004.2 2004-10-05
GBGB0422004.2A GB0422004D0 (en) 2004-10-05 2004-10-05 Method of deprotection
PCT/GB2005/003692 WO2006037950A1 (en) 2004-10-05 2005-09-23 Method of deprotection

Publications (3)

Publication Number Publication Date
JP2008515793A JP2008515793A (ja) 2008-05-15
JP2008515793A5 true JP2008515793A5 (https=) 2008-11-06
JP5000521B2 JP5000521B2 (ja) 2012-08-15

Family

ID=33428035

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007534071A Expired - Fee Related JP5000521B2 (ja) 2004-10-05 2005-09-23 脱保護の方法

Country Status (6)

Country Link
US (1) US7714115B2 (https=)
EP (1) EP1797029A1 (https=)
JP (1) JP5000521B2 (https=)
CN (1) CN101035755B (https=)
GB (1) GB0422004D0 (https=)
WO (1) WO2006037950A1 (https=)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070260267A1 (en) * 2002-10-07 2007-11-08 Nicoson Zachary R Localizing obturator
PL2106808T3 (pl) * 2006-12-21 2018-07-31 Nihon Medi-Physics Co., Ltd. Promieniotwórczy znacznik do obrazowania diagnostycznego zawierający kwas 1-amino-3-[18F]fluorocyklobutanokarboksylowy
KR101408727B1 (ko) 2006-12-27 2014-06-17 니혼 메디피직스 가부시키가이샤 방사성 할로겐 표식 유기 화합물의 전구체 화합물의 제조 방법
TWI406674B (zh) * 2007-02-13 2013-09-01 日本藥學物理公司 Method for manufacturing diagnostic radiographic diagnostic agents
EP2005970A1 (de) 2007-06-22 2008-12-24 Berlin Science Partners GmbH i.V. Bildgebende Diagnostik durch Kombination von Kontrastmitteln
US8043316B2 (en) 2008-05-02 2011-10-25 Suros Surgical Systems, Inc. Adjustable spacer
GB0905515D0 (en) * 2009-03-31 2009-05-13 Ge Healthcare Ltd Radiolabelling methods
AU2010321278B2 (en) * 2009-11-17 2014-08-14 Piramal Imaging Sa Method for production of F-18 labeled glutamic acid derivatives
WO2011157443A1 (en) * 2010-06-17 2011-12-22 N.V. Organon (11b,17a)-11-(4-(2-11c-acetyl)phenyl)-17,23-epoxy-19,24-dinorchola-4,9,20-trien-3-one
CA2823063C (en) * 2010-12-29 2020-08-11 Ge Healthcare Limited A method for preparation of f for use in a radiofluorination reaction
US9101895B2 (en) 2011-04-15 2015-08-11 General Electric Company System for mixing and dispersing microbubble pharmaceuticals
KR101221483B1 (ko) * 2011-05-13 2013-01-16 서강대학교산학협력단 Ｆ-18 표지 방사성의약품 합성 장치 및 방법
US11534494B2 (en) 2011-12-21 2022-12-27 Ge Healthcare Limited Formulation and method of synthesis
GB201411569D0 (en) 2014-06-30 2014-08-13 Ge Healthcare Ltd Novel formulation and method of synthesis
KR20140102700A (ko) * 2011-12-21 2014-08-22 지이 헬쓰케어 리미티드 시트레이트 완충제 내 18ｆ―플루시클로빈 조성물
WO2015188165A1 (en) * 2014-06-06 2015-12-10 The Regents Of The University Of California Self-shielded, benchtop chemistry system
HUE069964T2 (hu) * 2016-06-10 2025-04-28 Univ Johns Hopkins Javított eljárás a radiojelölt prosztata-specifikus membrán antigén (prostate-specific membrane antigen, psma) gátló [18f]DCFPyL elõállítására
EP3551232B1 (en) * 2016-12-07 2022-03-23 Università degli Studi di Bari "Aldo Moro" Stable f-dopa formulations and uses thereof
JP7159157B2 (ja) * 2017-06-23 2022-10-24 日本メジフィジックス株式会社 放射性フッ素標識化合物の製造方法および放射性医薬の製造方法
JPWO2022196734A1 (https=) * 2021-03-17 2022-09-22

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5135683A (en) 1991-03-28 1992-08-04 Arco Chemical Technology, L.P. Process for producing a deprotected alkoxylated polyol
US5393908A (en) * 1992-06-25 1995-02-28 Satyamurthy; Nagichettiar Synthesis of N-formyl-3,4-di-t-butoxycarbonyloxy-6-(trimethylstannyl)-L-phenylalanine ethyl ester and its regioselective radiofluorodestannylation to 6-[18 F]fluoro-L-dopa
DE4330889C2 (de) * 1993-09-11 2002-10-31 Emtec Magnetics Gmbh Verfahren zur Wiedergewinnung von Rohmaterialien aus magnetischen Aufzeichnungsträgern
US5922810A (en) 1995-07-31 1999-07-13 Fmc Corporation Deprotection of protected functional polymers
BE1010280A3 (fr) 1996-05-02 1998-05-05 Coincidence S A Procede et dispositif de synthese de 2-[18f] fluoro-2-deoxy-d-glucose.
DE10104250A1 (de) 2001-01-31 2002-08-14 Deutsches Krebsforsch Markierungsfähige Verbindungen zur einfachen Synthese von 3'-[18F]Fluor-3'-deoxythymidin und Verfahren zu deren Herstellung
EP1356827A1 (en) * 2002-04-24 2003-10-29 Mallinckrodt Inc. Method for obtaining a 2-18F-fluor-2-deoxy-D-glucose (18F-FDG)-solution
US7022872B2 (en) 2003-12-19 2006-04-04 Molecular Technologies, Inc. Method for making fluorine labeled L-Dopa

Similar Documents

Publication Publication Date Title
JP2008515793A5 (https=)
CN101094824B (zh) 在醇溶剂中制备有机氟化物的方法
JP5188492B2 (ja) β−アルコキシプロピオンアミド類の製造方法
SK76898A3 (en) Method for the synthesis of benzimidazole compounds
US20160009827A1 (en) An Improved Process for Preparation of Sugammadex Sodium
JP2008528445A5 (https=)
JP2009527517A5 (https=)
JP2008515793A (ja) 脱保護の方法
HRP20191589T1 (hr) Postupci za pripravu derivata galnac kiseline
AR076969A1 (es) Un procedimiento para la preparacion de febuxostat
JP2013517320A5 (https=)
JP2008540414A5 (https=)
KR20180091672A (ko) 디뉴클레오사이드 폴리포스페이트 화합물의 제조방법
WO2002051781A1 (fr) Procede permettant de preparer un compose d'halohydrine optiquement actif
JP4629322B2 (ja) シロスタゾールの製造法
ES2751698T3 (es) Procedimiento para la preparación del éster etílico del ácido 1-(2-halogen-etil)-4-piperidina-carboxílico
US8076499B2 (en) Method for preparing precursor of radioactive 3-iodobenzylguanidine
RU2673540C2 (ru) Способ получения левотироксина и его солей
CA2671816A1 (en) Salts of imidazole-5-carboxylic acid derivatives, a method for preparing same and pharmaceutical compositions comprising same
US11332489B2 (en) Process for preparing imetelstat
CA2606799C (en) Process for synthesis of proton pump inhibitors
Bourdier et al. Synthesis and stability of S‐(2‐[18F] fluoroethyl)‐L‐homocysteine for potential tumour imaging
JP6018578B2 (ja) Ｐｅｔ前駆体の製造
CN102906076A (zh) 考布他汀衍生物制备方法
CN101654433B (zh) 一种2-吡啶酮的n-烷基化方法